Physician profile
David Sikule
NPI 1669976932
$5,381.08
in general payments reported to CMS, 2019-2025
22 companies · $2,798 in 2025
The $2,798 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $283 · 2023: $1,097 · 2024: $1,203 · 2025: $2,798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,227 · Travel and Lodging: $1,857 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,226.76 |
| Travel and Lodging | $1,856.68 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,503.23 | 2022-2025 | General - Kidney Stone Disease, Ams 700, Axonics |
| Coloplast Corp | $729.37 | 2023 | Titan |
| Procept Biorobotics Corporation | $395.44 | 2024-2025 | Aquabeam System |
| Teleflex LLC | $285.49 | 2025 | Urolift, Barrigel |
| Valencia Technologies Corporation | $200.44 | 2024 | Ecoin Device Kit |
| Axonics, INC. | $187.64 | 2023-2024 | Bulkamid, Axonics |
| Dendreon Pharmaceuticals LLC | $168.49 | 2024 | Provenge |
| Urogen Pharma, INC. | $122.88 | 2023 | Jelmyto |
| Bluewind Medical | $113.22 | 2024 | Revi |
| Histosonics, INC. | $108.41 | 2025 | |
| Olympus America INC. | $106.64 | 2023 | Itind System, Soltive |
| Intuitive Surgical, INC. | $78.32 | 2024 | |
| Merck Sharp & Dohme LLC | $70.53 | 2024-2025 | Welireg, Keytruda |
| Janssen Scientific Affairs, LLC | $66.97 | 2025 | Erleada |
| Calyxo, INC. | $60.75 | 2025 | Cvac Aspiration System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $46.67 | 2025 | Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $36.73 | 2025 | |
| Angiodynamics, INC. | $27.54 | 2023 | Nanoknife |
| Novartis Pharmaceuticals Corporation | $23.26 | 2024 | |
| Ferring Pharmaceuticals INC. | $17.67 | 2024 | Adstiladrin |
| Endo Pharmaceuticals INC. | $16.39 | 2023 | Xiaflex |
| Becton, Dickinson and Company | $15.00 | 2025 | Bard X-Force Balloon Dilation Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sikule listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.